SYK
★★☆☆☆ PassmistralStryker Corporation
Healthcare
Session move
$331.37
Vol 1.32× avg
68/100 quant · tgt $382.88
RS60 +2.4% vs SPY · ADV$ 809.8M
pushed 2026-08-19T10:27 · Pre-market · Pushed snapshot
Since last scan
2026-08-18 → 2026-08-19
Context only — not a buy/sell signal. Built from scan history and cached news/filings.
Snapshot quote
session 2026-08-18 · scan 2026-08-19 · pushed 2026-08-19T10:27 · Pre-market
Show quote fundamentalsHide quote fundamentals
- Last (scan/close)
- $331.37
- Previous close
- $331.68
- Pushed last
- $331.37 · Pre-market
- Session open
- $337.00
- Last session range
- $331.04 – $339.24
- 52-week range
- $280.25 – $392.86
- Session volume
- 3,179,817
- Avg volume (20d)
- 2,408,316
- Market cap
- $127.10B
- PE (TTM)
- 34.37
- Forward PE
- 19.77
- Dividend yield
- 1.05%
- 1y target est.
- $382.88
- Next earnings
- 2026-10-29
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. Pre/after-hours quotes are thinner and may differ from the regular session.
If you put $1,000 in
1y ago
$858
−14%
5y ago
$1,316
+32%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
Market briefing
Curated digest — not a trade signal. Headlines and links as provided by the producer.
- How Much More Can Boston Scientific Stock Move After Losing Half Its Value?
Options price a band whose floor sits below anything the stock has touched in the past year, and the company's own recovery timetable lands after that window closes.
Yahoo · 2026-08-13
- Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.
Yahoo · 2026-08-13
- Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?
Stryker's 13.6% three-month rally reflects stronger sales, margins and production, but execution risks and a premium peer valuation could test further gains.
Yahoo · 2026-08-13
- Intuitive Surgical: Priced For Precision
Intuitive Surgical (ISRG) stock analysis: Hold rating with $426.65 price target (+9% upside).
SeekingAlpha · 2026-08-12
Reddit mentions
Public Reddit titles via the official API — unofficial, delayed, not a trade signal. Not affiliated with Reddit. Opens Reddit.
No recent Reddit titles matched this ticker.
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — Stryker's 16% EPS growth and 44% earnings surprise rate support sustained operational leverage in high-margin MedTech segments like orthopedics and spine.
- Risks — High debt-to-equity (64x) and trailing P/E of 34x limit valuation upside despite strong fundamentals.
- Target Upside — Mean price target of $382.88 implies 15.5% upside from current $331.37.
Score History
13 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-08-19$331.37-0.3168.2Pass
- 2026-08-18$331.68-7.5370.4Watch
- 2026-08-17$339.21-1.8870.1Watch
- 2026-08-14$341.09-0.6170.3Watch
- 2026-08-13$341.69-6.4570.3Watch
- 2026-08-12$348.15+2.3471.9Watch
- 2026-08-11$345.81+8.3872.5Watch
- 2026-08-07$337.43+0.4071.2Watch
- 2026-08-06$337.03+1.0771.2Watch
- 2026-08-05$335.96-5.2471.5Watch
- 2026-08-03$341.20+15.5064.5Pass
- 2026-08-01$325.70+3.3066.3Pass
- 2026-07-31$322.40—66.0Pass
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 31.5%
- vs 20d (z)
- -2.70
- Short vol
- 414,178
- Status
- ok
Squeeze pressure score
full30/100
- Short leg
- 14
- Call leg
- 62
- Activity
- 5.7
- Call vol share
- 72.7%
- PCR (vol)
- 0.38
- Call OI share
- —
- ATM IV
- 0.0%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
Disclosure score
Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.
Disclosure score
-8
- News
- 0
- Insider
- -8
- Earnings
- 0
Signals below are rule hits from cached filings — Risk / Constructive / Attention. Attention is not a bullish call. Linked chips open the SEC original when available.
Risk (−)
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
Earnings surprise (quant context)
From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.
Last reported surprise +0.4%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-29yahoo_calendar
- Last earnings
- —
- SEC ↗42026-08-18
FORM 4
- SEC ↗42026-08-04
FORM 4
- SEC ↗42026-08-04
FORM 4
- SEC ↗42026-08-04
FORM 4
- SEC ↗42026-08-04
FORM 4
- SEC ↗10-Q2026-07-31
10-Q
- SEC ↗8-K2026-07-30
8-K
- SEC ↗8-K2026-06-26
8-K
- SEC ↗42026-06-02
FORM 4
- SEC ↗42026-05-29
FORM 4
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.